Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS). 2004

Cristina Vanoni, and Silvia Massari, and Marco Losa, and Paolo Carrega, and Carla Perego, and Laura Conforti, and Grazia Pietrini
Department of Pharmacology, School of Medicine, C.E.N.D. Center of Excellence on Neurodegenerative Diseases, University of Milan, IN-CNR Cellular and Molecular Pharmacology Section, Via Vanvitelli 32, 20129 Milano, Italy.

It has been suggested that glutamate-induced excitotoxicity plays a central role in the development of motor neuron diseases such as amyotrophic lateral sclerosis (ALS). The GLT-1 isoform of the glutamate transporter gene family is the most important transporter involved in keeping extracellular glutamate concentration below neurotoxic levels. Its loss and an increase in extracellular glutamate has been documented in cases of sporadic and familial ALS, as well as in animal models expressing ALS-linked Cu2+-Zn2+ superoxide dismutase (SOD1) mutations, but the underlying molecular mechanisms are still unclear. We developed and characterised a cell model consisting of polarised epithelial Madin-Darby Canine Kidney (MDCK) cell lines stably expressing wild-type SOD1 or the ALS-linked SOD1 G93A mutant, and analysed the expression of glutamate transporters after transient transfection of the corresponding cDNAs. Like ALS patients and animal models of ALS, the G93A-expressing MDCK cell system showed reduced total glial GLT-1 expression, with no change in the expression of the neuronal EAAC1 glutamate transporter isoform. Morphological analysis revealed the intracellular redistribution of GLT-1 to acidic compartments, whereas the surface distribution of other glutamate transporters (neuronal EAAC1 and glial GLAST) was not affected. Moreover, mutant SOD1 affected the cytosolic tail of GLT-1 because reduced protein expression of EAAC-GLT but not GLT-EAAC chimeras was found in G93A-expressing cell lines. GLT-1 downregulation was greatly induced by inhibition of protein synthesis, and prevented by treatment with chloroquine aimed at inhibiting the activity of acidic degradative compartments. Negligible effect on the protein level or distribution of GLT-1 was observed in cells overexpressing wild-type SOD1. The specific decrease in the GLT-1 isoform of glutamate transporters is therefore recapitulated in G93A-expressing MDCK cell lines, thus suggesting an autonomous cell mechanism underlying the loss of GLT-1 in ALS. Our data indicate that the continuous expression of mutant SOD1 causes the downregulation of GLT-1 by increasing the internalisation and degradation of the surface transporter, and suggest that the cytosolic tail of GLT-1 is required to target the transporter to degradation.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004705 Endocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Endocytoses

Related Publications

Cristina Vanoni, and Silvia Massari, and Marco Losa, and Paolo Carrega, and Carla Perego, and Laura Conforti, and Grazia Pietrini
July 1995, Annals of neurology,
Cristina Vanoni, and Silvia Massari, and Marco Losa, and Paolo Carrega, and Carla Perego, and Laura Conforti, and Grazia Pietrini
June 1977, Diseases of the nervous system,
Cristina Vanoni, and Silvia Massari, and Marco Losa, and Paolo Carrega, and Carla Perego, and Laura Conforti, and Grazia Pietrini
September 1996, Annals of neurology,
Cristina Vanoni, and Silvia Massari, and Marco Losa, and Paolo Carrega, and Carla Perego, and Laura Conforti, and Grazia Pietrini
September 1999, Nature neuroscience,
Cristina Vanoni, and Silvia Massari, and Marco Losa, and Paolo Carrega, and Carla Perego, and Laura Conforti, and Grazia Pietrini
May 1999, Nature neuroscience,
Cristina Vanoni, and Silvia Massari, and Marco Losa, and Paolo Carrega, and Carla Perego, and Laura Conforti, and Grazia Pietrini
January 2009, Neurochemistry international,
Cristina Vanoni, and Silvia Massari, and Marco Losa, and Paolo Carrega, and Carla Perego, and Laura Conforti, and Grazia Pietrini
January 2017, Biochemical and biophysical research communications,
Cristina Vanoni, and Silvia Massari, and Marco Losa, and Paolo Carrega, and Carla Perego, and Laura Conforti, and Grazia Pietrini
December 1996, Experimental neurology,
Cristina Vanoni, and Silvia Massari, and Marco Losa, and Paolo Carrega, and Carla Perego, and Laura Conforti, and Grazia Pietrini
March 2016, Experimental neurology,
Cristina Vanoni, and Silvia Massari, and Marco Losa, and Paolo Carrega, and Carla Perego, and Laura Conforti, and Grazia Pietrini
January 2012, Journal of the neurological sciences,
Copied contents to your clipboard!